In light of Vyleesi being approved by the FDA for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women its time to revisit the science behind PT-141 (Bremelanotide). This peptide is the only legitimate aphrodisiac that activates libido and arousal in women. It also works in men in higher doses than those used in women. We will discuss all aspects of use of this peptide and any unwanted effects.
Along with her almost 25 years in practice in non-surgical orthopedics, and her Stanford-affiliated Fellowship in Sports and Spine Medicine, Dr. Yurth has received her American Board of Anti-Aging/Regenerative Medicine (ABAARM) Board Certification from the American Academy of Anti-Aging Medicine (A4M), has completed her Fellowship in Anti-Aging and Regenerative Medicine (FAARM) and her Advanced Fellowship in Anti-Aging, Regenerative and Functional Medicine (FAARFM) also through A4M. She has also completed an independent fellowship in Epigenetic and Human Potential Medicine and is now part of the nation's very first cohort of Certified Peptide Specialiist through A4M. Dr. Yurth is an inaugural member of the International Peptide Society (IPS) and is an IPS/A4M faculty member and lecturer.